MRCP2-4035
A 67-year-old man visits the nephrology outpatient department for his yearly review appointment. He has a medical history of stage IIIb chronic kidney disease and hypertension. He takes amlodipine, ramipril, and doxazosin. He is a non-smoker and non-drinker who lives alone and works as a non-executive director for a multinational company.
During his visit, his vital signs are heart rate 84 beats per minute, blood pressure 156/88 mmHg, respiratory rate 16/minute, oxygen saturation 98% on room air, and temperature 36.7ºC. Physical examination reveals a well-looking man who is clinically euvolemic. Cardio-respiratory and abdominal examinations are unremarkable.
The consultant reviews his recent blood tests, which show Hb 124 g/L, platelets 189* 109/L, WBC 9.2 * 109/L, Na+ 137 mmol/L, K+ 4.2 mmol/L, urea 8.9 mmol/L, creatinine 184 µmol/L, CRP 4 mg/L, adjusted calcium 2.01 mmol/L, phosphate 1.81 mmol/L, albumin 38 g/L, ALP 145 IU/L, and parathyroid hormone 7.6 pg/L.
What is the best initial approach to managing his mineral bone disease associated with chronic kidney disease?